Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.